Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001193125-10-093111
Filing Date
2010-04-26
Accepted
2010-04-26 14:28:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM 10-12G d1012ga.htm 10-12G/A 713420
2 CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO., LLP dex231.htm EX-23.1 1436
3 filename3.htm CORRESP 14808
  Complete submission text file 0001193125-10-093111.txt   730746
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-12G/A | Act: 34 | File No.: 000-27436 | Film No.: 10770016
SIC: 2836 Biological Products, (No Diagnostic Substances)